dr. ferrajoli on the fda approval of ibrutinib in cll
Published 10 years ago • 617 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
2:18
dr. ferrajoli on ibrutinib as treatment for patients with cll
-
2:11
dr. ferrajoli on treatment of elderly patients with cll
-
2:38
dr. ferrajoli on the management of cll in elderly patients
-
1:18
dr. ferrajoli on individualized treatment of cll
-
1:07
dr. ferrajoli on remaining challenges in treatment of cll
-
0:59
dr. rule on the fda approval of zanubrutinib in mcl
-
1:20
dr. byrd provides an update on ibrutinib in cll
-
22:26
what's your approach? treating myelofibrosis
-
5:50
idelalisib in chronic lymphocytic leukemia
-
5:35
front-line chemoimmunotherapy in chronic lymphocytic leukemia
-
1:38
dr. tendler on breakthrough designation for ibrutinib
-
1:30
dr. fenske discusses disease progression on ibrutinib in mcl
-
5:51
venetoclax in chronic lymphocytic leukemia
-
9:58
dr. graeme fraser - cll patient prognosis
-
8:09
novel treatment approaches to relapsed/refractory cll
-
2:45
optimizing the combination of ibrutinib plus venetoclax in cll
-
1:01
dr. von tresckow on "sequential triple-t" trial in cll
-
0:26
acalabrutinib plus venetoclax and rituximab in the treatment of mcl
-
1:10
dr. younes discusses the future of treating lymphoid malignancies